CXCL8 and breast cancer: Yokoe et al. have measured serum IL-8 levels in 12 heavily pretreated patients with recurrent breast cancer and reported a small increase of IL-8 in those patients with refractory progressive disease and almost no decrease in those with partial response or no change after systemic therapy9.